| Product NDC: | 63323-270 | 
| Proprietary Name: | Propofol | 
| Non Proprietary Name: | PROPOFOL | 
| Active Ingredient(s): | 10 mg/mL & nbsp; PROPOFOL | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, EMULSION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 63323-270 | 
| Labeler Name: | APP Pharmaceuticals, LLC | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA019627 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20091007 | 
| Package NDC: | 63323-270-57 | 
| Package Description: | 20 VIAL in 1 BOX (63323-270-57) > 50 mL in 1 VIAL | 
| NDC Code | 63323-270-57 | 
| Proprietary Name | Propofol | 
| Package Description | 20 VIAL in 1 BOX (63323-270-57) > 50 mL in 1 VIAL | 
| Product NDC | 63323-270 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | PROPOFOL | 
| Dosage Form Name | INJECTION, EMULSION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20091007 | 
| Marketing Category Name | NDA | 
| Labeler Name | APP Pharmaceuticals, LLC | 
| Substance Name | PROPOFOL | 
| Strength Number | 10 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |